Due to the everlasting need to offer cost effective contraception alternatives to prevent unwanted pregnancies and the resulting health risks and social consequences that result, various research institutions and commercial drug companies are conducting research on new reversible male contraceptive alternatives.
With SpermCheck® Contraception, ContraVac will answer the need for a conformational diagnostic test to accurately assess the effectiveness of male contraceptive drug therapies by monitoring a man’s fertility status.
ContraVac is currently conducting feasibility studies using our prototype devices with a pharmaceutical company that has a successful female reproductive health franchise.
|
